News Coverage 07.23.19 By: Amber Tong Share on Twitter Share on Facebook Share on LinkedIn PACT Pharma says it’s perfected the tech to select neoantigens for personalized therapy — now onto the clinic Related Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment